Andrew Schreiner

Has grant

Associate Professor of Medicine

Medical University of South Carolina

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Improving the Diagnosis and Fibrosis Risk Assessment of Nonalcoholic Fatty Liver Disease in Primary Care Patients with Abnormal Liver Chemistries

Open Date: 2022-05-15

Close Date: 2024-04-30

Grant: Close

Improving the Diagnosis of Liver Disease in Primary Care Patients with Abnormal Liver Function

Open Date: 2018-07-17

Close Date: 2023-02-28

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Josep Vilaseca

Chief of Service

SPAIN

View details

David Koch

Associate Professor

Medical University of South Carolina

UNITED STATES

View details

Kelly Casler

Associate Clinical Professor

Ohio State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrew Schreiner

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (18)

Objective Measures of Cardiometabolic Risk and Advanced Fibrosis Risk Progression in Primary Care Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Statin prescriptions and progression of advanced fibrosis risk in primary care patients with MASLD

Hospitalization as an opportunity to improve lung cancer screening in high-risk patients.

Real-World Primary Care Data Comparing ALT and FIB-4 in Predicting Future Severe Liver Disease Outcomes

Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease

Identifying Patients with Nonalcoholic Fatty Liver Disease in Primary Care: How and for What Benefit?

Is hospitalization a missed opportunity to intervene on tobacco cessation?

FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care: A Time-dependent Cox Regression Analysis.

Statin prescribing patterns in patient-centered medical home patients with NAFLD.

Chronic liver disease is not associated with statin prescription in a primary care cohort.

"I'm Not Good with Money" and Other Lies Residents Tell Themselves about Personal Finance.

FIB-4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine-Gray competing risk analysis

It Is Time for Financial Wellness Curricular Interventions

Longitudinal, Spaced-Learning POCUS Curriculum for Internal Medicine Residents to Improve Knowledge and Skills

Nonalcoholic Fatty Liver Disease Underdiagnosis in Primary Care: What Are We Missing?

The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care

The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint

Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort.

Collaborators (3)

Josep Vilaseca

David Koch

Kelly Casler

Make your next move.